Alok B.
- Country
- Norway
- Department
- Department of Neurology
Research Overview
Data & Insights
Has run more than one trial at 3 of 17 partner sites.
Specializations
Oncology – Advanced Solid Tumors
Investigates therapeutic options for advanced solid tumors spanning lung, gastrointestinal, breast, and urothelial sites.
- Checkpoint inhibitor‑based regimens
- KRAS‑G12C targeted therapies
- Biomarker‑guided treatment pathways
Emphasis is placed on integrating immunotherapy with chemotherapy and novel targeted agents.
Hematologic Malignancies – Myeloma and Leukemia
Focuses on innovative approaches for multiple myeloma and acute leukemias, including refractory disease settings.
- Proteasome inhibitor combinations
- CD38‑directed bispecific antibodies
- FLT3‑targeted kinase inhibitors
Projects aim to improve depth of response and prolong survival in high‑risk patients.
Neurology – Neurodegenerative and Cerebrovascular Disorders
Leverages expertise from the Department of Neurology to address conditions such as Alzheimer’s disease, amyotrophic lateral sclerosis, and acute ischemic stroke.
- Neuroprotective agent trials
- Disease‑modifying therapies for dementia
- Acute reperfusion strategies for stroke
Research integrates clinical outcomes with biomarker assessments to guide treatment selection.
Cardiovascular & Renal – Stroke, Atrial Fibrillation, Heart Failure, CKD
Explores interventions for cardiovascular and renal disease intersections, including anticoagulation in chronic kidney disease.
- Novel oral anticoagulants in atrial fibrillation
- Anti‑inflammatory agents for heart failure with preserved ejection fraction
- Renoprotective combos for stage 5 CKD
Studies target reduction of thrombo‑embolic events and preservation of renal function.
Autoimmune & Inflammatory – Rheumatology and Dermatology
Addresses chronic immune‑mediated conditions such as rheumatoid arthritis, Sjögren’s syndrome, and hidradenitis suppurativa.
- Therapeutic drug monitoring for biologics
- Targeted cytokine inhibition
- Topical and systemic treatments for skin inflammation
Efforts aim to achieve sustained disease control while minimizing adverse effects.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
